{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T07:29:29Z","timestamp":1763105369926},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1472-6750-14-38","type":"journal-article","created":{"date-parts":[[2014,5,10]],"date-time":"2014-05-10T13:01:44Z","timestamp":1399726904000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recombinant fusion protein of cholera toxin B subunit with YVAD secreted by Lactobacillus caseiinhibits lipopolysaccharide-induced caspase-1 activation and subsequent IL-1 beta secretion in Caco-2 cells"],"prefix":"10.1186","volume":"14","author":[{"given":"Yukihiro","family":"Hiramatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatatsu","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomitsu","family":"Satho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Irie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Uyeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Fukumitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Toda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Miake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Kashige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,10]]},"reference":[{"key":"918_CR1","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1128\/CVI.00169-08","volume":"15","author":"B del Rio","year":"2008","unstructured":"del Rio B, Dattwyler RJ, Aroso M, Neves V, Meirelles L, Seegers JF, Gomes-Solecki M: Oral immunization with recombinant Lactobacillus plantarum induced a protective immune response in mice with Lyme disease. Clin Vaccine Immunol. 2008, 15: 1429-1435. 10.1128\/CVI.00169-08.","journal-title":"Clin Vaccine Immunol"},{"key":"918_CR2","first-page":"1266","volume":"18","author":"SW Jung","year":"2008","unstructured":"Jung SW, Kim WJ, Lee KG, Kim CW, Noh WS: Fermentation characteristics of exopolysaccharide-producing lactic acid bacteria from sourdough and assessment of the isolates for industrial potential. J Microbiol Biotechnol. 2008, 18: 1266-1273.","journal-title":"J Microbiol Biotechnol"},{"key":"918_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0168-1605(98)00048-8","volume":"41","author":"PH Pouwels","year":"1998","unstructured":"Pouwels PH, Lee RJ, Shaw M, den Bak-Glashouwer MJ H, Tielen FD, Smit E, Martinez B, Jore J, Conway PL: Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int J Food Microbiol. 1998, 41: 155-167. 10.1016\/S0168-1605(98)00048-8.","journal-title":"Int J Food Microbiol"},{"key":"918_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF01872268","volume":"69","author":"PH Fishman","year":"1982","unstructured":"Fishman PH: Role of membrane ganglioside in the binding and action of bacterial toxins. J Membr Biol. 1982, 69: 85-97. 10.1007\/BF01872268.","journal-title":"J Membr Biol"},{"key":"918_CR5","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1248\/bpb.b12-01021","volume":"36","author":"T Okuno","year":"2013","unstructured":"Okuno T, Kashige N, Satho T, Irie K, Hiramatsu Y, Sharmin T, Fukmits Y, Uyeda S, Harakuni T, Miyata T, Arakawa T, Imoto M, Toda A, Nakashima Y, Miake F: Expression and secretion of cholera toxin B subunit in lactobacilli. Biol Pharm Bull. 2013, 36: 952-958. 10.1248\/bpb.b12-01021.","journal-title":"Biol Pharm Bull"},{"key":"918_CR6","doi-asserted-by":"publisher","first-page":"5654","DOI":"10.1128\/IAI.73.9.5654-5665.2005","volume":"73","author":"T Harakuni","year":"2005","unstructured":"Harakuni T, Sugawa H, Komesu A, Tadano M, Arakawa T: Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to taeget recombinant vaccine antigens to mucosal immune systems. Infect Immun. 2005, 73: 5654-5665. 10.1128\/IAI.73.9.5654-5665.2005.","journal-title":"Infect Immun"},{"key":"918_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/bit.20654","volume":"92","author":"Y Yuki","year":"2005","unstructured":"Yuki Y, Hara-Yakoyama C, Guadiz AA, Udaka S, Kiyono H, Chatterjee S: Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune disease. Biotechnol Bioeng. 2005, 92: 803-809. 10.1002\/bit.20654.","journal-title":"Biotechnol Bioeng"},{"key":"918_CR8","doi-asserted-by":"publisher","first-page":"32608","DOI":"10.1074\/jbc.273.49.32608","volume":"273","author":"M Garcia-Calvo","year":"1998","unstructured":"Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW, Thornberry NA: Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem. 1998, 273: 32608-32613. 10.1074\/jbc.273.49.32608.","journal-title":"J Biol Chem"},{"key":"918_CR9","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/356768a0","volume":"356","author":"NA Thornberry","year":"1992","unstructured":"Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J, Ding GJF, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju SM, Rolando AM, Salley JP, Yamin TT, Lee TD, Shively JE, MacCross M, Mumford RA, Schmidt JA, Tocci MJ: A novel heterodimetric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature. 1992, 356: 768-774. 10.1038\/356768a0.","journal-title":"Nature"},{"key":"918_CR10","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1136\/gut.30.6.835","volume":"30","author":"YR Mahida","year":"1989","unstructured":"Mahida YR, Wu K, Jewell DP: Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn\u2019s disease. Gut. 1989, 30: 835-838. 10.1136\/gut.30.6.835.","journal-title":"Gut"},{"key":"918_CR11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood.V91.2.577","volume":"91","author":"RR Schumann","year":"1998","unstructured":"Schumann RR, Belka C, Reuter D, Lamping N, Kirschning CJ, Weber JR, Pfeil D: Lipopolysaccharide activates caspase-1 (interleukin-1-converting enzyme) in cultured monocytic and eondothelial cells. Blood. 1998, 91: 577-584.","journal-title":"Blood"},{"key":"918_CR12","doi-asserted-by":"publisher","first-page":"9378","DOI":"10.1074\/jbc.270.16.9378","volume":"270","author":"P Ramage","year":"1995","unstructured":"Ramage P, Cheneval D, Chvei M, Graff P, Hemmig R, Heng R, Kocher HP, Mackenzie A, Memmert K, Revesz L, Wishart W: Expression, refolding, and autocatalytic proteolytic processing of the interleukin-1 beta-converting enzyme precursor. J Biol Chem. 1995, 270: 9378-9383. 10.1074\/jbc.270.16.9378.","journal-title":"J Biol Chem"},{"key":"918_CR13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bmcl.2011.10.102","volume":"22","author":"JD Charrier","year":"2012","unstructured":"Charrier JD, Durrant SJ, Studley J, Lawes L, Weber P: Synthesis and evauation of novel prodrugs of caspase inhibitors. Bioorg Med Chem Lett. 2012, 22: 485-488. 10.1016\/j.bmcl.2011.10.102.","journal-title":"Bioorg Med Chem Lett"},{"key":"918_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1365-2567.2002.01413.x","volume":"106","author":"H Sadeghi","year":"2002","unstructured":"Sadeghi H, Bregenholt S, Wegmann D, Petersen JS, Holmgren J, Lebens M: Genetic fusion of human insulin B-chain to the B subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo. Immunology. 2002, 106: 237-245. 10.1046\/j.1365-2567.2002.01413.x.","journal-title":"Immunology"},{"key":"918_CR15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.pep.2010.07.013","volume":"74","author":"TG Kim","year":"2010","unstructured":"Kim TG, Kim HY, Yang MS: Cholera toxin B subunit-domain \u0399\u0399\u0399 of dengue virus envelope glycoprotein E fusion protein production in transgenic plants. Protein Expr Purif. 2010, 74: 236-241. 10.1016\/j.pep.2010.07.013.","journal-title":"Protein Expr Purif"},{"key":"918_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0022-1759(97)00170-1","volume":"210","author":"S Liljegvist","year":"1997","unstructured":"Liljegvist S, St\u00e5hl S, Andr\u00e9oni C, Binz H, Uhl\u00e9n M, Murby M: Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding. J Immunol Methods. 1997, 210: 125-135. 10.1016\/S0022-1759(97)00170-1.","journal-title":"J Immunol Methods"},{"key":"918_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/protein\/11.7.577","volume":"11","author":"MT Dertzbaugh","year":"1998","unstructured":"Dertzbaugh MT, Cox LM: The affinity of cholera toxin for Ni2+ ion. Protein Eng. 1998, 11: 577-581. 10.1093\/protein\/11.7.577.","journal-title":"Protein Eng"},{"key":"918_CR18","doi-asserted-by":"publisher","first-page":"831704","DOI":"10.1155\/2011\/831704","volume":"2011","author":"Q Meng","year":"2011","unstructured":"Meng Q, Wang W, Shi X, Jin Y, Zhang Y: Protection against autoimmune diabetes by silkworm-produced GFP-tagged CTB-insulin fusion protein. Clin Dev Immunol. 2011, 2011: 831704-","journal-title":"Clin Dev Immunol"},{"key":"918_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.micinf.2012.11.003","volume":"15","author":"Y Hiramatsu","year":"2013","unstructured":"Hiramatsu Y, Satho T, Irie K, Shiimura S, Okuno T, Sharmin T, Uyeda S, Fukumitsu Y, Nakashima Y, Miake F, Kashige N: Differences in TLR9-dependent inhibitory effects of H2O2-induced IL-8 secretion and NF-kappa B\/I kappa B-alpha system activation by genomic DNA from five Lactobacillus species. Microbes Infect. 2013, 15: 96-104. 10.1016\/j.micinf.2012.11.003.","journal-title":"Microbes Infect"},{"key":"918_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J: The inflammasome: a molecular platform triggering acivation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002, 10: 417-426. 10.1016\/S1097-2765(02)00599-3.","journal-title":"Mol Cell"},{"key":"918_CR21","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/j.1365-2443.2004.00789.x","volume":"9","author":"M Yamamoto","year":"2004","unstructured":"Yamamoto M, Yaginuma K, Tsutsui H, Sagara J, Guan X, Seki E, Yasuda K, Yamamoto M, Akira S, Nakanishi K, Noda T, Taniguchi S: ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules. Genes Cells. 2004, 9: 1055-1067. 10.1111\/j.1365-2443.2004.00789.x.","journal-title":"Genes Cells"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6750-14-38.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:00:30Z","timestamp":1630555230000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/1472-6750-14-38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,10]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["918"],"URL":"https:\/\/doi.org\/10.1186\/1472-6750-14-38","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,10]]},"assertion":[{"value":"1 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"38"}}